La pénurie de traitements à base d’agonistes opioïdes met en péril la vie de plus de 1'200 patients. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.
By István Gábor Takács / Rights Reporter Foundation
Organisations in Lebanon providing Opioid Agonist Treatment ask for international help to maintain the programs. Watch our short video and take action!
OAT, Opioid Agonist Treatment Program was legalized and launched in Lebanon in 2012 within the Harm Reduction Program, after years of advocacy from harm reduction actors in the country.
In light of the compounded and ongoing crises that have hit Lebanon since 2019, today organisations are facing the risk of yet another health crisis with the imminent shortage of Opioid Agonist Treatment medication. Organizations providing the treatment in Lebanon have learnt of the upcoming shortage of OAT medication which leaves the lives of over 1200 individuals hanging in the balance.
Watch this short video with Elie Aaraj, Executive Director of the Middle East and North Africa Harm Reduction Association, explaining the problem: